Abstract A novel human gene determining a polypeptide product of 478 residues with an estimated molecular mass of 55kDa, which has significant homology and structural similarity to Bos UDP-N-acetylglucosamine: α-1,3-D-mannoside -1,4-N-acetylglucosaminyltransferase (GnT-IV), was cloned from the commonly deleted region in pancreatic cancer at 12q21. The gene is composed of at least six exons, and the last three exons cover the open reading frame. Different sized transcripts, 3.8-kb in the heart, brain, and fetal brain and 2.8-kb and 1.7-kb in the testis were observed by Northern blot analysis. By reverse transcription-polymerase chain reaction, expression was also observed in the adult brain, liver, and adrenal gland, but not in pancreas. Because of its significant homology and structural similarity to Bos GnT-IV, it is potentially the gene encoding human GnT-IV or its homologue, which had been one of two genes remaining to be cloned in the human GnT family.
Introduction
Chromosome band 12q21 is a locus implicated in cancers of the pancreas and stomach (Fey et al. 1980; Sano et al. 1991; Kimura et al. 1996; Fukushige et al. 1997; Kimura et al. 1998) . We previously identified a commonly deleted region in pancreatic cancer at 12q21 between D12S81 and D12S1719 (Kimura et al. 1998 ).
Methods and results
In the search for a candidate tumor suppressor gene, the deleted region was covered with bacterial artificial chromosome (BAC) clones and cosmid clones subcloned from yeast artificial chromosome (YAC) clones. Then shotgun sequencing was carried out to determine the nucleotide (nt) sequences of the deleted region. Several expressed sequence tags (ESTs) were found to be located in this area. One of the ESTs, AA385488 (GenBank; http:// www.ncbi.nlm.nih.gov/Web/Genbank), was located in the deleted region. A paired primer set, primers 5Ј-GGAAACATCCACACATCAACTG-3Ј and 5Ј-TGCTA-GGTGAACCACCACTG-3Ј, was used to amplify a 257-bp fragment corresponding to a partial sequence of the EST by reverse transcription-polymerase chain reaction (RT-PCR) according to methods described previously (Mori et al. 1997) . Using the PCR product as a probe, we isolated 15 independent cDNA clones from a fetal brain cDNA library (Clontech, Palo Alto, CA, USA). After analysis of nucleotide sequences determined with an ABI prism BigDye Terminator Cycle Sequencing Ready Reaction FS Kit and an ABI prism 377 DNA sequencer (Perkin-Elmer Applied Biosystems, Foster City, CA, USA), two types of sequences were obtained. These were generated by alternative splicing mechanisms (see below).
The first sequence (type 1 transcript, accession no. AB024729) was composed of 2655-nt with open reading frame encoding for a polypeptide of 478 amino acid residues with an estimated molecular mass of 55kDa. The second sequence (type 2 transcript, accession no. AB024730) lacked a sequence consisting of 121-nt within the 5Ј untranslated region of the first sequence. In-frame termination codons were found upstream of the predicted initiation codon. The homology search for the predicted protein utilized the National Center of Biotechnology Information (NCBI) position specific iterated basic local alignment search tool (PSI-BLAST) (http://www.ncbi.nlm.nih.gov/cgibin/BLAST/nph-psi_blast). We found that the predicted product had high homology with Bos UDP-Nacetylglucosamine:
α-1,3-D-mannoside -1,4-Nacetylglucosaminyltransferase (GnT-IV) (accession no. AB000628). The identity of the predicted amino acid sequence of the gene to bovine GnT-IV protein (Bos GnT-IV) was 27%, and the similarity was 45% (see Fig. 1 ). It contained a highly hydrophobic region close to the N-terminus between Val-26 and Tyr-42, followed by a hydrophilic region between Ser-44 and Ser-77; this could be a transmembrane domain and a stem region. A similar structure including a large hydrophobic region with a subsequent hydrophilic region is observed in the N-terminal region between Val-8 and Tyr-25 of Bos GnT-IV. This structure corresponds to type II transmembrane protein, which is commonly observed in other human GnTs (see below). Because of its significant homology to Bos GnT-IV, the cDNA we isolated is thought to have been derived from the gene encoding human GnT-IV or its homologue. We named this gene human GnT-IV homologue (hGnT-IV-H). It is notable that the predicted protein product of the hGnT-IV-H gene lacked a proline-rich sequence in the predicted stem region (similar to Bos GnT-IV), which exists in other N-acetylglucosaminyltransferases (GnTs).
GnT-IV is an essential enzyme for the synthesis of the multiantennary structure of asparagine (Asn)-linked oligosaccharides, which are mainly contained in erythropoietin and α1 acid glycoprotein (Gleeson and Schachter 1983; Minowa et al. 1998) . Together with GnT-V, this protein contributes to phenotypic changes in neoplastic transformed cells by inducing a structural change in cell surface carbohydrates, known as increased sialyation, and by 1-6-linked branching of complex-type Asn-linked oligosaccharides (Schachter, 1986) . This structural change is directly associated with the metastatic potential of neoplastic transformed cells (Dennis et al. 1987) . There are six different human GnTs known so far; GnT-I (UDP-N-acetylglucosamine: α-1,3-D-mannoside -1,2-N-acetylglucosa- (Looijenga et al. 1990) . The green signals indicate the human GnT-IV-H (BAC759H8), which was located at 12q21. B Northern blot analysis of hGnT-IV-H. A radiolabelled cDNA fragment containing the C-terminal coding region and 3Ј untranslated region (UTR) was used for hybridization of Human MTN Blot (H) and MTN Blot IV (H4), and a cDNA fragment harboring the entire coding region was used for hybridization of the Fetal MTN Blot II (F) (Clontech for all Blots). Different sized transcripts, 3.8-kb in the heart, brain, and the fetal brain (indicated by arrowheads), and 2.8-kb and 1.7-kb in the testis (indicated by asterisks) were observed. Nonspecific hybridizations of 28S and 18S ribosomal RNAs were observed in the blot of fetal tissues. C Reverse minyltransferase), GnT-II (UDP-N-acetylglucosamine: α-1,6-D-mannoside -1,2-N-acetylglucosaminyltransferase), GnT-III (UDP-N-acetylglucosamine: -D-mannoside -1,4-N-acetylglucosaminyltransferase) and GnT-V (UDP-Nacetylglucosamine:
α-1,6-D-mannoside -1,6-Nacetylglucosaminyltransferase V) have been cloned and characterized. GnT-I is an essential molecule for mouse development because its knockout is lethal (Ioffe and transcription-polymerase chain reaction (RT-PCR) for hGnT-IV-H and the adenomatous polyposis coli (APC) gene in various normal adult tissues, including brain, lung, thyroid gland, salivary gland, esophagus, liver, pancreas, kidney, adrenal gland, and uterus. Primers for hGnT-IV-H were 5Ј-TGATTCTGCGTGAGAAAGGC-3Ј in exon 1 and 5Ј-GAACGTTTTCTCAGGCATCTC-3Ј in exon 4. Results of Southern hybridization using a radiolabelled oligonucleotide, 5Ј-AAGACGCTGTCATAATCTGTGC-3Ј in exon 2 are shown. RT-PCR for the APC gene as a control was performed using primers 5Ј-TGGGTTCTTCTGGACAGATT-3Ј and 5Ј-TCAGCAAGAAGCAATGACCT-3Ј. Southern hybridization using a radiolabelled oligonucleotide 5Ј-GGACTGCACTCTCCAGAAC-3Ј is shown Stanley, 1994) . GnT-II is the putative gene for carbohydratedeficient glycoprotein syndrome type II (Tan et al. 1996) . GnT-III is assumed to be related to the promotion and metastasis of certain tumors, including hepatic tumor and mouse melanoma (Yoshimura et al. 1995; Bhaumik et al. 1998 ). Thus, GnTs are important enzymes in regard to both physiology and pathology. In the human GnTs family, GnT-IV and GnT-VI remain to be cloned and characterized.
To determine the genomic structure of hGnT-IV-H, the BAC clone 759H8 (Research Genetics, Huntsville, AL, USA) harboring the EST fragment was sequenced. The gene was composed of at least six exons, and exon 4 through exon 6 harbored an open reading frame (see Fig. 2 ). Sequences of exon-intron junctions were deposited in the database (accession nos. AB024906 through AB024911). After comparison of the genomic and cDNA sequences, we found that the type 2 transcript lacked the entire exon 3, by alternative splicing. The BAC clone also contained a microsatellite marker, D12S88, indicating that this gene is very close to this marker. Localization of the gene at 12q21 was confirmed by fluorescence in situ hybridization (FISH) (see Fig. 3A ) according to a method described previously .
Expression of hGnT-IV-H was analyzed by Northern blot and RT-PCR. Human Multiple Tissue Northern (MTN) Blot, Human MTN Blot IV, and Human Fetal MTN Blot II (Clontech) were hybridized according to the manufacturer's instructions with a 32 P-labelled cDNA fragment containing the C-terminal coding region and the 3Ј untranslated region (UTR) for the former two blots, and a cDNA fragment harboring the entire coding region for the fetal blot. A 3.8-kb transcript was detected in the heart, brain, and fetal brain tissues. Two different sized transcripts, 2.8-kb and 1.7-kb in size, were detected in the testis (see Fig. 3B ). To study the expression of the two types of isolated transcripts, we carried out RT-PCR for cDNAs generated from the mRNAs of various normal adult tissues, including brain, lung, thyroid gland, salivary gland, esophagus, liver, pancreas, kidney, adrenal gland, and uterus, according to a method described previously (Mori et al. 1997) . A primer pair localizing in exons 1 and 4 was used. By Southern hybridization of the RT-PCR products, using an oligonucleotide in exon 2, we observed relatively abundant transcripts in adult brain, whereas only trace amounts of transcripts were detected in liver and adrenal gland (see Fig. 3C ). These transcripts corresponded to the type 2 transcript, which produced a 167-bp product.
Discussion
Because the hGnT-IV-H gene was located at a frequently deleted locus in pancreatic cancer, there was a possibility that this gene had a role in pancreatic carcinogenesis. However, expression of hGnT-IV-H was not detected in pancreatic tissue by Northern blot or RT-PCR, as shown in Fig.  3B ,C. RT-PCR with a different primer pair located in exons 5 and 6 within the coding region also failed to detect expression of the gene in the pancreas (data not shown). Hence, it is very likely that the hGnT-IV-H gene does not play any role in pancreatic carcinogenesis. We also analyzed 19 pancreatic cancer cell lines, but no expression was detected in these specimens by RT-PCR.
We have cloned a novel human gene located in the region at 12q21 deleted in pancreatic cancer. The gene encoded a polypeptide of 478 residues with an estimated molecular mass of 55 kDa. The encoded polypeptide product showed a significant homology with and structural similarities to Bos GnT-IV and is therefore the gene potentially encoding human GnT-IV or its homologue. Its biological and pathological roles should be clarified in future investigations.
The nucleotide sequence data reported in this manuscript will appear in the DDBJ, EMBLE, and GenBank nucleotide sequence databases with the following accession numbers: AB024729, AB024730, and AB024906 through AB024911.
